en-GBde-DEja-JPes-ES
MagVenture NEWS

Are you interested in TMS? Stay updated and subscribe to MagVenture NEWS

Read More
Depression treatment for Patients

Do you not respond to antidepressants?
TMS is an effective alternative to medication

Read More
MagVenture Depression Treatment for healthcare professionals

Do you wish to give patients an alternative to antidepressants?

Read More
MagVenture MagPro R30 Stimulator

Magnetic stimulation systems for depression treatment, clinical examination and research

Read More
MagVenture Coils

With 7 different magnetic stimulators and 33 different coils, MagVenture is the ultimate research partner

Read More
< Back
You are here » About  »  News and Events  »  News

Sign Up for the MagVenture Newsletter

Get the latest news about MagVenture and magnetic stimulation directly in your inbox – press on the button below and fill out the form:

MagVenture News

25 Latest Articles
May 05, 2017 

MagPro R20 receives FDA clearance for depression

MagVenture has received FDA 510(k) clearance to market the MagVita TMS Therapy with MagPro R20 for treatment of Major Depressive Disorder in adult patients who have failed to receive satisfactory improvement from prior antidepressant medication in the current episode.

With this clearance, MagVenture now offers an entry-level solution for small or start-up clinics who want to offer rTMS depression treatment to a limited number of patients per day. This FDA clearance is a supplement to the already FDA-cleared high-performance solutions for clinics treating a large number of patients per day.

Read press release 

Read FDA clearance

 

Researchers

Researcher

Healthcare Professionals

Healthcare Professional

Products

Download

Download Brochure